{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:42Z","timestamp":1786119222222,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,2,27]]},"DOI":"10.1097\/tp.0b013e318163619f","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T10:12:33Z","timestamp":1236247953000},"page":"507-516","source":"Crossref","is-referenced-by-count":9,"title":["Campath-1H Induction Therapy in African American and Hispanic First Renal Transplant Recipients: 3-Year Actuarial Follow-Up"],"prefix":"10.1097","volume":"85","author":[{"given":"Gaetano","family":"Ciancio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Gaynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichiro","family":"Sageshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lissett","family":"Tueros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Kupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet","family":"Esquenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaver transplantation.","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00007890-199711150-00008","article-title":"Immunosuppressive therapy in high-risk transplant patients: Dose-dependent efficacy of mycophenolate mofetil in African-American renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.","volume":"64","author":"Neylan","year":"1997","journal-title":"Transplantation"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00007890-199802270-00011","article-title":"Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.","volume":"65","author":"Neylan","year":"1998","journal-title":"Transplantation"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1034\/j.1600-6143.2003.00181.x","article-title":"The use of daclizumab, tacrolimus, and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients.","volume":"3","author":"Ciancio","year":"2003","journal-title":"Am J Transplant"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/00007890-199911270-00032","article-title":"Campath 1H allows low-dose cyclosporine monotherapy in 31 cadaveric renal allograft recipients.","volume":"68","author":"Calne","year":"1999","journal-title":"Transplantation"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/01.TP.0000065192.53065.50","article-title":"Preliminary experience with Campath-1H (C1H) in intestinal and liver transplantation.","volume":"75","author":"Tzakis","year":"2003","journal-title":"Transplantation"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.surg.2004.06.015","article-title":"Campath-1H in renal transplantation: The University of Wisconsin experience.","volume":"136","author":"Knechtle","year":"2004","journal-title":"Surgery"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1111\/j.1600-6143.2005.01067.x","article-title":"Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction\u2013long-term results.","volume":"5","author":"Kaufman","year":"2005","journal-title":"Am J Transplant"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine.","volume":"16","author":"Cockcroft","year":"1976","journal-title":"Nephron"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/ki.1993.259","article-title":"International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology.","volume":"44","author":"Solez","year":"1993","journal-title":"Kidney Int"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00007890-199908150-00011","article-title":"Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial.","volume":"68","year":"1999","journal-title":"Transplantation"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1097\/00007890-200006150-00033","article-title":"Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection.","volume":"69","author":"Ojo","year":"2000","journal-title":"Transplantation"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1097\/00007890-200204150-00015","article-title":"Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.","volume":"73","author":"Ciancio","year":"2002","journal-title":"Transplantation"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.TP.0000128625.29654.EB","article-title":"The use of Campath-1H as induction therapy in renal transplantation: Preliminary results.","volume":"78","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: Evolution in practice and trends, 1994\u20132004.","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00007890-199902270-00021","article-title":"Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells.","volume":"67","author":"Khanna","year":"1999","journal-title":"Transplantation"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1097\/00007890-199812270-00029","article-title":"Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group.","volume":"66","author":"Solez","year":"1998","journal-title":"Transplantation"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/01.TP.0000081042.67285.91","article-title":"A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients.","volume":"76","author":"Goggins","year":"2003","journal-title":"Transplantation"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.TP.0000089440.47239.3F","article-title":"Withdrawal of steroid ther-apy in African American kidney transplant recipients receiving sirolimus and tacrolimus.","volume":"76","author":"Hricik","year":"2003","journal-title":"Transplantation"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1399-0012.2004.00298.x","article-title":"Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies.","volume":"19","author":"Kumar","year":"2005","journal-title":"Clin Transplant"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate mofetil versus cyclosporine (NEORAL)\/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.tp.0000203894.53714.27","article-title":"A randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate versus cyclosporine\/sirolimus in renal transplantation: Three-year analysis.","volume":"81","author":"Ciancio","year":"2006","journal-title":"Transplantation"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1600-6143.2005.00822.x","article-title":"Alemtuzumab (CAMPATH IH) induction therapy in cadaveric kidney transplantation efficacy and safety at five years.","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-200802270-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:50:27Z","timestamp":1786038627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-200802270-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,27]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e318163619f","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2,27]]}}}